Azurity Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved Danziten, the first and only nilotinib with no mealtime restrictions indicated for adult patients with ...

AI-driven MRI solution, icobrain aria receives US FDA clearance for safer Alzheimer’s treatment: Boston Saturday, November 16, 2024, 16:00 Hrs [IST] icometrix, a g ...

LEO Pharma’s Anzupgo cream to treat chronic hand eczema receives marketing approval in Switzerland: Ballerup, Denmark Saturday, November 16, 2024, 15:00 Hrs [IST] LEO Pharma A/S ...

Peethaambaran Kunnathoor, Chennai Saturday, November 16, 2024, 08:00 Hrs [IST] ...

Paras Health to open its first hospital in Punjab’s Ludhiana;10th hospital in India: Our Bureau, Mumbai Friday, November 15, ...

Entod Pharmaceuticals in collaboration with the MATANAND Welfare Foundation and Paediatric Ophthalmological Society of India ...

Osivax announces first participant vaccinated in phase 2a clinical booster trial of influenza vaccine candidate OVX836: Lyon, France Saturday, November 16, 2024, 14:00 Hrs [IST] O ...

Yashoda Medicity organizes “Crown of Courage” ceremony to honour cancer survivors: Our Bureau, Mumbai Friday, November 15, ...

EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...

New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...

WHO & US CDC new estimates show measles cases surge worldwide, infecting 10.3 million people in 2023: Geneva Saturday, November 16, 2024, 10:00 Hrs [IST] Worldwide, there were an ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...